-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Looking Forward: Novel Therapeutic Approaches in Chronic and Advanced Phases of Myelofibrosis

Program: Education Program
Session: Myeloproliferative Neoplasms: A Clinical Update
Saturday, December 5, 2015, 7:30 AM-9:00 AM
W224, Level 2 (Orange County Convention Center)
Saturday, December 5, 2015, 4:00 PM-5:30 PM
W224, Level 2 (Orange County Convention Center)

John O. Mascarenhas, MD, MS

Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY

Disclosures: Mascarenhas: Novartis Pharmaceuticals Corporation: Research Funding ; Promedior: Research Funding ; Incyte Corporation: Research Funding ; Roche: Research Funding ; CTI Biopharma: Research Funding ; Kalobios: Research Funding .

See more of: Myeloproliferative Neoplasms: A Clinical Update
See more of: Education Program
Previous Presentation | Next Presentation >>